ArticleFrontiers in oncology2025

Benefit-risk evaluation of Fuzheng Yiliu Decoction combined with chemotherapy for treating non-small cell lung cancer using multicriteria decision analysis.

Dongjing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.